FTC Biosimilars Workshop: Second Time’s The Charm?
This article was originally published in The Pink Sheet Daily
Executive Summary
Having failed to significantly influence the design of the federal approval pathway, the Commission is hoping to have an impact on product naming and state substitution laws.